The Global Repurposed Drugs market was valued at US$ 2.1 billion in 2023 and is projected to reach US$ 4.3 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period (2023-2030).
Report Overview
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
This report provides a deep insight into the global Repurposed Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Repurposed Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Repurposed Drugs market in any manner.
Global Repurposed Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Teva
- Novartis
- Mylan
- Johnson & Johnson
- Pfizer
- Bausch Health
- GSK
- ChemRar Group
- Glenmark
- Fujifilm
- Dr. Reddy
- R-Pharma
- Including or excluding key companies relevant to your analysis.
Market Segmentation (by Type)
- Generic Drugs
- Clinical Trial Failed Drugs
Market Segmentation (by Application)
- Cardiovascular Diseases
- Mental Illness
- Cancer
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Repurposed Drugs Market
- Overview of the regional outlook of the Repurposed Drugs Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Repurposed Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Repurposed Drugs
1.2 Key Market Segments
1.2.1 Repurposed Drugs Segment by Type
1.2.2 Repurposed Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Repurposed Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Repurposed Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Repurposed Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Repurposed Drugs Market Competitive Landscape
3.1 Global Repurposed Drugs Sales by Manufacturers (2019-2024)
3.2 Global Repurposed Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Repurposed Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Repurposed Drugs Sales Sites, Area Served, Product Type
3.6 Repurposed Drugs Market Competitive Situation and Trends
3.6.1 Repurposed Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Repurposed Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Repurposed Drugs Industry Chain Analysis
4.1 Repurposed Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Repurposed Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Repurposed Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Repurposed Drugs Sales Market Share by Type (2019-2024)
6.3 Global Repurposed Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Repurposed Drugs Price by Type (2019-2024)
7 Repurposed Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Repurposed Drugs Market Sales by Application (2019-2024)
7.3 Global Repurposed Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Repurposed Drugs Sales Growth Rate by Application (2019-2024)
8 Repurposed Drugs Market Segmentation by Region
8.1 Global Repurposed Drugs Sales by Region
8.1.1 Global Repurposed Drugs Sales by Region
8.1.2 Global Repurposed Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Repurposed Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Repurposed Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Repurposed Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Repurposed Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Repurposed Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Teva
9.1.1 Teva Repurposed Drugs Basic Information
9.1.2 Teva Repurposed Drugs Product Overview
9.1.3 Teva Repurposed Drugs Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Repurposed Drugs SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Novartis
9.2.1 Novartis Repurposed Drugs Basic Information
9.2.2 Novartis Repurposed Drugs Product Overview
9.2.3 Novartis Repurposed Drugs Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Repurposed Drugs SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Mylan
9.3.1 Mylan Repurposed Drugs Basic Information
9.3.2 Mylan Repurposed Drugs Product Overview
9.3.3 Mylan Repurposed Drugs Product Market Performance
9.3.4 Mylan Repurposed Drugs SWOT Analysis
9.3.5 Mylan Business Overview
9.3.6 Mylan Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Repurposed Drugs Basic Information
9.4.2 Johnson and Johnson Repurposed Drugs Product Overview
9.4.3 Johnson and Johnson Repurposed Drugs Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Pfizer
9.5.1 Pfizer Repurposed Drugs Basic Information
9.5.2 Pfizer Repurposed Drugs Product Overview
9.5.3 Pfizer Repurposed Drugs Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Bausch Health
9.6.1 Bausch Health Repurposed Drugs Basic Information
9.6.2 Bausch Health Repurposed Drugs Product Overview
9.6.3 Bausch Health Repurposed Drugs Product Market Performance
9.6.4 Bausch Health Business Overview
9.6.5 Bausch Health Recent Developments
9.7 GSK
9.7.1 GSK Repurposed Drugs Basic Information
9.7.2 GSK Repurposed Drugs Product Overview
9.7.3 GSK Repurposed Drugs Product Market Performance
9.7.4 GSK Business Overview
9.7.5 GSK Recent Developments
9.8 ChemRar Group
9.8.1 ChemRar Group Repurposed Drugs Basic Information
9.8.2 ChemRar Group Repurposed Drugs Product Overview
9.8.3 ChemRar Group Repurposed Drugs Product Market Performance
9.8.4 ChemRar Group Business Overview
9.8.5 ChemRar Group Recent Developments
9.9 Glenmark
9.9.1 Glenmark Repurposed Drugs Basic Information
9.9.2 Glenmark Repurposed Drugs Product Overview
9.9.3 Glenmark Repurposed Drugs Product Market Performance
9.9.4 Glenmark Business Overview
9.9.5 Glenmark Recent Developments
9.10 Fujifilm
9.10.1 Fujifilm Repurposed Drugs Basic Information
9.10.2 Fujifilm Repurposed Drugs Product Overview
9.10.3 Fujifilm Repurposed Drugs Product Market Performance
9.10.4 Fujifilm Business Overview
9.10.5 Fujifilm Recent Developments
9.11 Dr. Reddy
9.11.1 Dr. Reddy Repurposed Drugs Basic Information
9.11.2 Dr. Reddy Repurposed Drugs Product Overview
9.11.3 Dr. Reddy Repurposed Drugs Product Market Performance
9.11.4 Dr. Reddy Business Overview
9.11.5 Dr. Reddy Recent Developments
9.12 R-Pharma
9.12.1 R-Pharma Repurposed Drugs Basic Information
9.12.2 R-Pharma Repurposed Drugs Product Overview
9.12.3 R-Pharma Repurposed Drugs Product Market Performance
9.12.4 R-Pharma Business Overview
9.12.5 R-Pharma Recent Developments
10 Repurposed Drugs Market Forecast by Region
10.1 Global Repurposed Drugs Market Size Forecast
10.2 Global Repurposed Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Repurposed Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Repurposed Drugs Market Size Forecast by Region
10.2.4 South America Repurposed Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Repurposed Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Repurposed Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Repurposed Drugs by Type (2025-2030)
11.1.2 Global Repurposed Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Repurposed Drugs by Type (2025-2030)
11.2 Global Repurposed Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Repurposed Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Repurposed Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Repurposed Drugs Market Size Comparison by Region (M USD)
Table 5. Global Repurposed Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Repurposed Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Repurposed Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Repurposed Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repurposed Drugs as of 2022)
Table 10. Global Market Repurposed Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Repurposed Drugs Sales Sites and Area Served
Table 12. Manufacturers Repurposed Drugs Product Type
Table 13. Global Repurposed Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Repurposed Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Repurposed Drugs Market Challenges
Table 22. Global Repurposed Drugs Sales by Type (Kilotons)
Table 23. Global Repurposed Drugs Market Size by Type (M USD)
Table 24. Global Repurposed Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Repurposed Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Repurposed Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Repurposed Drugs Market Size Share by Type (2019-2024)
Table 28. Global Repurposed Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Repurposed Drugs Sales (Kilotons) by Application
Table 30. Global Repurposed Drugs Market Size by Application
Table 31. Global Repurposed Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Repurposed Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Repurposed Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Repurposed Drugs Market Share by Application (2019-2024)
Table 35. Global Repurposed Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Repurposed Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Repurposed Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Repurposed Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Repurposed Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Repurposed Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Repurposed Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Repurposed Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Repurposed Drugs Basic Information
Table 44. Teva Repurposed Drugs Product Overview
Table 45. Teva Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Business Overview
Table 47. Teva Repurposed Drugs SWOT Analysis
Table 48. Teva Recent Developments
Table 49. Novartis Repurposed Drugs Basic Information
Table 50. Novartis Repurposed Drugs Product Overview
Table 51. Novartis Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Repurposed Drugs SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Mylan Repurposed Drugs Basic Information
Table 56. Mylan Repurposed Drugs Product Overview
Table 57. Mylan Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Mylan Repurposed Drugs SWOT Analysis
Table 59. Mylan Business Overview
Table 60. Mylan Recent Developments
Table 61. Johnson and Johnson Repurposed Drugs Basic Information
Table 62. Johnson and Johnson Repurposed Drugs Product Overview
Table 63. Johnson and Johnson Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Recent Developments
Table 66. Pfizer Repurposed Drugs Basic Information
Table 67. Pfizer Repurposed Drugs Product Overview
Table 68. Pfizer Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Pfizer Business Overview
Table 70. Pfizer Recent Developments
Table 71. Bausch Health Repurposed Drugs Basic Information
Table 72. Bausch Health Repurposed Drugs Product Overview
Table 73. Bausch Health Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bausch Health Business Overview
Table 75. Bausch Health Recent Developments
Table 76. GSK Repurposed Drugs Basic Information
Table 77. GSK Repurposed Drugs Product Overview
Table 78. GSK Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. GSK Business Overview
Table 80. GSK Recent Developments
Table 81. ChemRar Group Repurposed Drugs Basic Information
Table 82. ChemRar Group Repurposed Drugs Product Overview
Table 83. ChemRar Group Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ChemRar Group Business Overview
Table 85. ChemRar Group Recent Developments
Table 86. Glenmark Repurposed Drugs Basic Information
Table 87. Glenmark Repurposed Drugs Product Overview
Table 88. Glenmark Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Glenmark Business Overview
Table 90. Glenmark Recent Developments
Table 91. Fujifilm Repurposed Drugs Basic Information
Table 92. Fujifilm Repurposed Drugs Product Overview
Table 93. Fujifilm Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Fujifilm Business Overview
Table 95. Fujifilm Recent Developments
Table 96. Dr. Reddy Repurposed Drugs Basic Information
Table 97. Dr. Reddy Repurposed Drugs Product Overview
Table 98. Dr. Reddy Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Dr. Reddy Business Overview
Table 100. Dr. Reddy Recent Developments
Table 101. R-Pharma Repurposed Drugs Basic Information
Table 102. R-Pharma Repurposed Drugs Product Overview
Table 103. R-Pharma Repurposed Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. R-Pharma Business Overview
Table 105. R-Pharma Recent Developments
Table 106. Global Repurposed Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Repurposed Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Repurposed Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Repurposed Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Repurposed Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Repurposed Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Repurposed Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Repurposed Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Repurposed Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Repurposed Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Repurposed Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Repurposed Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Repurposed Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Repurposed Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Repurposed Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Repurposed Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Repurposed Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Repurposed Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Repurposed Drugs Market Size (M USD), 2019-2030
Figure 5. Global Repurposed Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Repurposed Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Repurposed Drugs Market Size by Country (M USD)
Figure 11. Repurposed Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Repurposed Drugs Revenue Share by Manufacturers in 2023
Figure 13. Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Repurposed Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Repurposed Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Repurposed Drugs Market Share by Type
Figure 18. Sales Market Share of Repurposed Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Repurposed Drugs by Type in 2023
Figure 20. Market Size Share of Repurposed Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Repurposed Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Repurposed Drugs Market Share by Application
Figure 24. Global Repurposed Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Repurposed Drugs Sales Market Share by Application in 2023
Figure 26. Global Repurposed Drugs Market Share by Application (2019-2024)
Figure 27. Global Repurposed Drugs Market Share by Application in 2023
Figure 28. Global Repurposed Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Repurposed Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Repurposed Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Repurposed Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Repurposed Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Repurposed Drugs Sales Market Share by Country in 2023
Figure 37. Germany Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Repurposed Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Repurposed Drugs Sales Market Share by Region in 2023
Figure 44. China Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Repurposed Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Repurposed Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Repurposed Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Repurposed Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Repurposed Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Repurposed Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Repurposed Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Repurposed Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Repurposed Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Repurposed Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Repurposed Drugs Market Share Forecast by Application (2025-2030)
